Search results (40)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Researchers develop new tool to better predict AML outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Prof Anindita Roy awarded CRUK funding to study infant acute lymphoblastic leukaemia
30 May 2024
Congratulations to Professor Anindita Roy who successfully applied for a CRUK Data4CYP award!
World Cancer Day: Oxford University professors on the record with their contribution to the fight against cancer
4 February 2024
Principal Investigators at the University talk candidly about their work and how they’re helping the fight against cancer.
Disentangling a long-standing link between inflammation and cancer progression
11 September 2023
A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.
Public talk: Using blood tests to detect cancer
7 December 2022
Organised by the NIHR Oxford Biomedical Research Centre, Professor Mark Middleton and patient representative Sue Duncombe discuss how cancer blood tests are being assessed and how they may change how cancer is diagnosed in the NHS.
Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments
25 November 2022
Scientists from the University of Oxford's MRC Weatherall Institute of Molecular Medicine and the University of Birmingham have made the first bone marrow ‘organoids’ that include all the key components of human marrow. This technology allows for the screening of multiple anti-cancer drugs at the same time, as well as testing personalised treatments for individual cancer patients.
Profiling the entire cancer genome identifies new subgroups of blood cancer that can be used to predict likely clinical outcomes
4 November 2022
The University of Oxford has led the largest and most comprehensive analysis of the entire genomic landscape of the commonest type of blood cancer called chronic lymphocytic leukaemia (CLL) as part of the UK’s 100,000 Genomes Project
First patient diagnosed earlier using liquid biopsy technology as part of the AI-REAL programme in sub-Saharan Africa
8 August 2022
The AI-REAL programme led by Professor Anna Schuh and research teams in Tanzania and Uganda is improving the early detection and outcomes of childhood lymphoma in the region by increasing the speed and precision of diagnosis.
Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
24 May 2022
COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
Strong immune responses in myeloma patients after two doses of COVID vaccine
29 November 2021
A study of 214 patients with myeloma finds that 93% of them produced T cells as well as antibodies to the SARS-CoV-2 spike protein after two doses of a COVID vaccine.
New model for infant leukaemia announced
28 November 2021
The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
Identifying early clinical features of myeloma in primary care
1 November 2021
Research by Dr Karthik Ramasamy into the earlier recognition of myeloma symptoms in primary care aims to accelerate myeloma diagnosis.
Haematology workshops enable significant patient involvement
7 October 2021
The 'What Matters Most’ initiative was designed as a way of bringing people with Myelodyspastic Syndrome together to talk about their shared experience, and agree a list of priorities for research and service / resource development.
New atlas revealed of bone marrow haematopoiesis during development
1 October 2021
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Changes in blood cell production over the human lifetime may hold clues to patterns of disease
16 September 2021
A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood cancers.
World Chronic Lymphoid Leukaemia Day 2021
1 September 2021
Researchers from Oxford University and OUH are joining celebrations for the first world CLL day on 1 September 2021.
The next step in personalised cancer medicine
6 July 2021
Botnar Research Centre researchers have developed standalone long-read sequencing of single cells technology that could open new avenues into the causes of diseases like cancer.
Oxford Cancer welcomes Professor Stefan Constantinescu
5 July 2021
Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.
Two clinical academic research partnerships awarded to Oxford researchers
22 June 2021
Congratulations to Dr Karthik Ramasamy & Dr John Jacob on their CARP awards from the Medical Research Council. Find more about their work that is being funded.
Early diagnosis of lymphoma in children and young adults in sub-Saharan Africa
18 June 2021
A multidisciplinary team of researchers based in Oxford, Tanzania and Uganda are testing novel diagnostic tools and strengthening local capacity to improve early diagnosis of blood cancers called lymphomas, common diseases in children and young adults in sub-Saharan Africa